Total Payments
$2,193
2023 Payments
$65.63
Companies
12
Transactions
61
Medicare Patients
2,682
Medicare Billing
$175,283
Payment Breakdown by Category
Food & Beverage$2,193 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,193 | 61 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $804.47 | 20 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $462.86 | 16 | $0 (2021) |
| Sight Sciences, Inc. | $179.89 | 3 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $134.38 | 6 | $0 (2021) |
| Glaukos Corporation | $118.42 | 1 | $0 (2018) |
| Shire North American Group Inc | $115.69 | 1 | $0 (2018) |
| THE CAMERON-EHLEN GROUP, INC. | $114.09 | 2 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $92.77 | 2 | $0 (2017) |
| Aerie Pharmaceuticals, Inc. | $69.30 | 4 | $0 (2021) |
| Alcon Vision LLC | $48.45 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $65.63 | 1 | Sight Sciences, Inc. ($65.63) |
| 2022 | $100.27 | 1 | Sight Sciences, Inc. ($100.27) |
| 2021 | $371.79 | 15 | Allergan, Inc. ($92.32) |
| 2020 | $369.38 | 14 | Allergan, Inc. ($160.55) |
| 2019 | $521.50 | 13 | Allergan Inc. ($268.86) |
| 2018 | $500.87 | 11 | Allergan Inc. ($144.69) |
| 2017 | $263.34 | 6 | Allergan Inc. ($138.05) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/11/2023 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $65.63 | General |
| Category: Ophthalmology | ||||||
| 02/10/2022 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Food and Beverage | In-kind items and services | $100.27 | General |
| Category: Ophthalmology | ||||||
| 10/14/2021 | Allergan, Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $54.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/28/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Ophthalmology | ||||||
| 07/15/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: DRY EYE | ||||||
| 06/08/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), BromSite, Xelpros | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Ophthalmology | ||||||
| 05/26/2021 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Ophthalmology | ||||||
| 05/20/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Ophthalmology | ||||||
| 04/29/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Ophthalmology | ||||||
| 04/07/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Ophthalmology | ||||||
| 04/06/2021 | THE CAMERON-EHLEN GROUP, INC. | — | Food and Beverage | In-kind items and services | $89.91 | General |
| 03/10/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Ophthalmology | ||||||
| 03/09/2021 | Alcon Vision LLC | AcrySof IQ VIVITY IOL (Device) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Ophthalmology | ||||||
| 03/04/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Glaucoma | ||||||
| 03/03/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/16/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/27/2021 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Glaucoma | ||||||
| 12/16/2020 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Glaucoma | ||||||
| 11/25/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/18/2020 | Alcon Vision LLC | AcrySof (Device) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Ophthalmology | ||||||
| 11/18/2020 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: GLAUCOMA | ||||||
| 11/18/2020 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Glaucoma | ||||||
| 10/28/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: DRY EYE | ||||||
| 10/21/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/07/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 9 | 936 | 956 | $130,054 | $52,603 |
| 2020 | 11 | 1,746 | 1,845 | $246,501 | $122,679 |
Total Patients
2,682
Total Services
2,801
Medicare Billing
$175,283
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 611 | 615 | $93,155 | $38,151 | 41.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 94 | $10,774 | $3,988 | 37.0% |
| 66821 | Removal of recurring cataract in lens capsule using laser | Facility | 2021 | 11 | 11 | $4,511 | $2,529 | 56.1% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 72 | 72 | $6,625 | $2,437 | 36.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 36 | 37 | $4,249 | $1,786 | 42.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 25 | 35 | $2,581 | $1,331 | 51.6% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 54 | 54 | $3,564 | $1,027 | 28.8% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 18 | 18 | $3,150 | $863.81 | 27.4% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 20 | 20 | $1,445 | $490.50 | 33.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 1,118 | 1,139 | $172,563 | $88,928 | 51.5% |
| 66821 | Removal of recurring cataract in lens capsule using laser | Facility | 2020 | 29 | 29 | $10,397 | $7,256 | 69.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 123 | 144 | $14,634 | $6,319 | 43.2% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 126 | 132 | $12,117 | $5,310 | 43.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 88 | 99 | $11,286 | $4,965 | 44.0% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 117 | 121 | $7,986 | $2,894 | 36.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 57 | 90 | $6,570 | $2,519 | 38.3% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 18 | 18 | $3,150 | $1,701 | 54.0% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 43 | 45 | $3,194 | $1,247 | 39.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 16 | $2,360 | $828.20 | 35.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $2,244 | $711.32 | 31.7% |
About Dr. Eugene Sarno, M.D
Dr. Eugene Sarno, M.D is a Ophthalmology healthcare provider based in W Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306845086.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eugene Sarno, M.D has received a total of $2,193 in payments from pharmaceutical and medical device companies, with $65.63 received in 2023. These payments were reported across 61 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,193).
As a Medicare-enrolled provider, Sarno has provided services to 2,682 Medicare beneficiaries, totaling 2,801 services with total Medicare billing of $175,283. Data is available for 2 years (2020–2021), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location W Des Moines, IA
- Active Since 07/15/2005
- Last Updated 05/11/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1306845086
Products in Payments
- LUMIGAN (Drug) $459.06
- RESTASIS (Drug) $224.76
- VYZULTA (Drug) $216.36
- LOTEMAX SM (Drug) $141.08
- XIIDRA (Drug) $135.52
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $118.42
- OMNI(R) SURGICAL SYSTEM (US) (Device) $114.26
- LOTEMAX GEL (Drug) $111.64
- LOTEMAX (Drug) $86.55
- OMNI SURGICAL SYSTEM (Device) $65.63
- CEQUA (Drug) $60.28
- rocklatan (Drug) $49.66
- AcrySof (Device) $29.43
- BROMSITE (Drug) $28.70
- Symfony IOL (Medical Supply) $24.18
- COMBIGAN (Drug) $21.12
- Cequa (Drug) $20.10
- CyPass (Device) $20.10
- rhopressa (Drug) $19.64
- AcrySof IQ VIVITY IOL (Device) $19.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.